Pain Biomarker Study

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

371

Participants

Timeline

Start Date

March 21, 2018

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
MigraineCluster HeadacheTrigeminal Autonomic CephalgiaHemicrania ContinuaParoxysmal HemicraniaSUNCTShort-Lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing
Interventions
DRUG

Oral capsaicin

Subjects will drink a solution with capsaicin

DRUG

Topical capsaicin

Capsaicin cream will be applied to the skin of the forehead, cheek, or leg

DRUG

Intranasal capsaicin

Capsaicin cream will be applied to the nostril

OTHER

Cold Water Irrigation

Subjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)

OTHER

Medical Air

Subjects will be exposed to medical air

DRUG

Low Flow Oxygen

Subjects will be exposed to oxygen gas between 1-9 L/min

DRUG

High Flow Oxygen

Subjects will be exposed to oxygen gas between 10-25 L/min

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER